Global Vagus Nerve Stimulators (VNS) Medical Devices Market Pipeline Landscape Report 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Vagus Nerve Stimulators (VNS) – Medical Devices Pipeline Product Landscape, 2021” report has been added to ResearchAndMarkets.com’s offering.

The report provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A vagus nerve stimulator is an impulse generating device which is implanted surgically to send electrical impulses to the vagus nerve. It consists of an impulse generator and electrode leads.

Scope

• Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Vagus Nerve Stimulators (VNS) Overview

3 Products under Development

3.1 Vagus Nerve Stimulators (VNS) – Pipeline Products by Stage of Development

3.2 Vagus Nerve Stimulators (VNS) – Pipeline Products by Territory

3.3 Vagus Nerve Stimulators (VNS) – Pipeline Products by Regulatory Path

3.4 Vagus Nerve Stimulators (VNS) – Pipeline Products by Estimated Approval Date

3.5 Vagus Nerve Stimulators (VNS) – Ongoing Clinical Trials

4 Vagus Nerve Stimulators (VNS) – Pipeline Products under Development by Companies

4.1 Vagus Nerve Stimulators (VNS) Companies – Pipeline Products by Stage of Development

4.2 Vagus Nerve Stimulators (VNS) – Pipeline Products by Stage of Development

5 Vagus Nerve Stimulators (VNS) Companies and Product Overview

5.1 Adriakaim Inc Company Overview

5.2 Aucta Technologies Inc Company Overview

5.3 Boston Scientific Corp Company Overview

5.4 Cala Health Inc Company Overview

5.5 CerboMed GmbH Company Overview

5.6 Cyberonics Inc Company Overview

5.7 DuoCure Ltd. Company Overview

5.8 ElectroCore Inc Company Overview

5.9 Evren Technologies, Inc. Company Overview

5.10 Flint Rehabilitation Company Overview

5.11 FRD Accel LLC Company Overview

5.12 LivaNova PLC Company Overview

5.13 Medical University of South Carolina Company Overview

5.14 MicroTransponder Inc Company Overview

5.15 Nemechek Technologies LLC Company Overview

5.16 Neuroloop Gmbh Company Overview

5.17 Nexeon MedSystems Inc Company Overview

5.18 Otto Bock HealthCare GmbH Company Overview

5.19 Parasym Ltd Company Overview

5.20 Pulsus Medical LLC (Inactive) Company Overview

5.21 Purdue University Company Overview

5.22 Setpoint Medical Corp Company Overview

5.23 Soterix Medical Inc Company Overview

5.24 SUNY Downstate Medical Center Company Overview

5.25 Synergia Medical SA Company Overview

5.26 SzeleSTIM GmbH Company Overview

5.27 The Feinstein Institute for Medical Research Company Overview

5.28 Trifectas Medical Corp. Company Overview

5.29 University of Alabama Company Overview

5.30 University of Auckland Company Overview

5.31 University of Pittsburgh Company Overview

5.32 University of Wisconsin Madison Company Overview

6 Vagus Nerve Stimulators (VNS)- Recent Developments

6.1 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule

6.2 Nov 04, 2021: electroCore Announces Third Quarter 2021 Financial Results

6.3 Nov 03, 2021: LivaNova Reports Third Quarter 2021 Results

6.4 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021

6.5 Sep 30, 2021: electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference

6.6 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting

6.7 Aug 05, 2021: electroCore Announces Second Quarter 2021 Financial Results

6.8 Jul 28, 2021: LivaNova Reports Second Quarter 2021 Results and Appoints Alex Sharpsburg as Chief Financial Officer

6.9 Jul 13, 2021: electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance

6.10 Jun 22, 2021: Feinstein Institutes scientists observe vagus nerve stimulation effect on brain activity

6.11 May 27, 2021: Purdue University hires new chief information officer

6.12 May 24, 2021: Boston Scientific to Participate in Bernstein’s 37th Annual Strategic Decisions Conference

6.13 Apr 29, 2021: electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6

6.14 Apr 19, 2021: Scientists develop long-term vagus nerve implant for bioelectronic medicine research

6.15 Mar 11, 2021: electroCore announces fourth quarter and full year 2020 financial results

6.16 Mar 04, 2021: electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11

6.17 Mar 03, 2021: electroCore to Participate at Two Upcoming Investor Conferences

6.18 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule

6.19 Jan 20, 2021: LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/pyto5r

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900